UBE2L6
Ubiquitin/ISG15-conjugating enzyme E2 L6
Also known as: UB2L6_HUMAN, UBCH8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14933
- Gene
- UBE2L6
- Ensembl
- ENSG00000156587
- Chromosome
- 11
- Canonical length
- 153 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is highly similar in primary structure to the enzyme encoded by the UBE2L3 gene. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
153 residues, UniProt reviewed canonical sequence.
>O14933|UBE2L6
1 MMASMRVVKE LEDLQKKPPP YLRNLSSDDA NVLVWHALLL PDQPPYHLKA FNLRISFPPE
61 YPFKPPMIKF TTKIYHPNVD ENGQICLPII SSENWKPCTK TCQVLEALNV LVNRPNIREP
121 LRMDLADLLT QNPELFRKNA EEFTLRFGVD RPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2L6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 126 nTPM
Expression across tissuesHPA
Tissue
- liver: 126 nTPM
- spleen: 119 nTPM
- lymph node: 112 nTPM
- thymus: 106 nTPM
- salivary gland: 97 nTPM
- appendix: 87 nTPM
Single-cell type
- decidual stromal cells: 254 nCPM
- hofbauer cells: 196 nCPM
- esophageal basal cells: 106 nCPM
- esophageal suprabasal cells: 102 nCPM
- kupffer cells: 95 nCPM
- megakaryocytes: 87 nCPM
Immune cell
- total PBMC: 1,060 nTPM
- neutrophil: 842 nTPM
- intermediate monocyte: 639 nTPM
- non-classical monocyte: 559 nTPM
- classical monocyte: 536 nTPM
- T-reg: 515 nTPM
Brain region
- spinal cord: 90 nTPM
- thalamus: 89 nTPM
- medulla oblongata: 85 nTPM
- hypothalamus: 73 nTPM
- midbrain: 73 nTPM
- pons: 69 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- innate immune response
- ISG15-protein conjugation
- protein modification process
- protein polyubiquitination
- ubiquitin-dependent protein catabolic process
Molecular functions
- ISG15 transferase activity
- ubiquitin binding
- ubiquitin conjugating enzyme activity
- ubiquitin-protein transferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2L6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2L6 as an antibody target. Whether an autoantibody or antibody against UBE2L6 could matter depends on whether native UBE2L6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2L6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2L6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...